Immunopathogenesis of infection with the visceralizing Leishmania species.
about
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisCombination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasisTLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasisRegulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasisDevelopment of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisClinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigenGrowth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasisFitness of Leishmania donovani parasites resistant to drug combinationsMetabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid MetabolismImmunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral LeishmaniasisGenetic admixture in Brazilians exposed to infection with Leishmania chagasi.Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infectionGenetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan.Evolutionary and functional insights into Leishmania META1: evidence for lateral gene transfer and a role for META1 in secretion.Leishmania chagasi T-cell antigens identified through a double library screenResistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.Macrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi.Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds.Evaluation of FcγRIIIB-NA1/NA2 Polymorphism in Visceral LeishmaniasisLXR deficiency confers increased protection against visceral Leishmania infection in mice.Cutaneous Manifestations of Human and Murine LeishmaniasisAnimal models for the study of leishmaniasis immunology.Immune regulation during chronic visceral leishmaniasis.Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthine-guanine and xanthine phosphoribosyltransferases.Body weight as a determinant of clinical evolution in hamsters (Mesocricetus auratus) infected with Leishmania (Viannia) panamensisProgressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.Dual immune modulatory effect of vitamin A in human visceral leishmaniasis.Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi.UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in miceLeishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleenMechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.Immunobiology of visceral leishmaniasis.Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model.Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with Leishmania infantum.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.Association of pro-inflammatory cytokines and iron regulatory protein 2 (IRP2) with Leishmania burden in canine visceral leishmaniasis.Xenodiagnosis of Leishmania donovani in BALB/c mice using Phlebotomus orientalis: a new laboratory model.
P2860
Q27318412-AA470405-C709-49D6-901B-3B453130B598Q27341915-9322C424-1274-439C-982C-B3626E3BD154Q27346402-B5CC001C-2259-4E32-BC7C-C8CB30C46171Q28480551-2770B8BE-8F13-4538-AE7D-E1AD0E3039FCQ28486287-227DDBB0-5632-4D0C-90FD-C785FE2C7E56Q28539852-C6834F72-DB79-4801-B1C1-0CAFC4CA7EFEQ28540097-9A141189-11DD-4106-8AEC-06B94E3AD843Q28545794-3144B04E-E06C-4993-B8DC-A88F9109261AQ28548008-1FEB39E0-868A-410E-B907-DDA4AB4E32D6Q28552919-8D44398D-60BB-4182-AE76-4753F32D8627Q30438885-63D125BA-5F7C-4D33-BF82-D6CCC554CAF7Q30441556-9F6E4D07-D704-4190-BEC3-8F90F61C1B71Q30442586-F7130212-4025-4A1D-B499-DC687AE5916CQ30504573-BF8B509F-FA71-40E6-BBD4-519FC21C503FQ33258365-8DA3D534-DF13-4486-A586-805976F5301CQ33275038-25E5AFFE-5978-4F25-8713-0CE53868DE9AQ33346267-17E074CE-C052-4CA7-9F8A-2F13935CADB8Q33479120-58A6FC60-FE97-4F30-9346-FAF11789D5B2Q33640641-6B469C9D-24B1-4C2A-AFA9-09EB576058B0Q33754665-DA7E76C0-DA0F-42C4-8110-8789F3541E0CQ33839048-E8BC3403-17D7-4CC8-A061-28DA729819C7Q33859617-20C629B6-D65F-4E72-B09A-72C85907243AQ33881718-ADAAA2D6-56C8-4DE8-8FD6-6D653B5BC2C8Q33897846-3D664C63-E60F-4B56-BEC5-930BA0D50090Q33926482-6E8775D2-20C6-41DA-BC08-93D71A4C4BD1Q34139938-EBF9984E-A33E-4B7C-BE0A-44D523D4BF3AQ34275996-DAB3B7CB-8A6A-401C-AECA-5BAC7F28387FQ34314499-BC30825E-2936-4DC4-810F-228C789CC670Q34484497-E1DB20DE-AC22-449D-BEFB-F38ECE40DDC7Q34600718-EFDA4B51-9403-438C-B8D9-62CB2D385083Q34637852-51D8548B-7046-4821-B17C-09FAB97C9EAEQ34639315-D92188DE-C311-4C3C-A561-762981AAEFE3Q34641680-B8884722-78CB-4F9A-B451-17CA4778F799Q34662190-20A3B43E-2C36-484D-938A-0AFF52007819Q34665258-93BD64A9-5A34-41F5-977A-A2E6910E69F1Q34721430-8A6956E7-DFF2-40F4-ADCF-F860FEA77EA9Q34764466-559491A4-D20C-4D62-9FAB-ACF1DB3F4AE1Q34955529-00822F74-F40B-415E-BED5-D14912E5229DQ35022372-ED887B50-BF8E-46B6-8399-3FE99413CAF7Q35190896-4E341BDF-55C2-49D3-9043-72133F42A821
P2860
Immunopathogenesis of infection with the visceralizing Leishmania species.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Immunopathogenesis of infection with the visceralizing Leishmania species.
@ast
Immunopathogenesis of infection with the visceralizing Leishmania species.
@en
type
label
Immunopathogenesis of infection with the visceralizing Leishmania species.
@ast
Immunopathogenesis of infection with the visceralizing Leishmania species.
@en
prefLabel
Immunopathogenesis of infection with the visceralizing Leishmania species.
@ast
Immunopathogenesis of infection with the visceralizing Leishmania species.
@en
P2093
P1476
Immunopathogenesis of infection with the visceralizing Leishmania species.
@en
P2093
Mary E Wilson
Richard D Pearson
Selma M B Jeronimo
P304
P356
10.1016/J.MICPATH.2004.11.002
P577
2005-04-01T00:00:00Z